Sana Biotechnology
SANA
SANA
200 hedge funds and large institutions have $473M invested in Sana Biotechnology in 2026 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 66 increasing their positions, 56 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1% less funds holding
Funds holding: 203 → 200 (-3)
27% less capital invested
Capital invested by funds: $651M → $473M (-$179M)
Holders
200
Holding in Top 10
3
Calls
$2.17M
Puts
$577K
Top Buyers
| 1 | +$9.78M | |
| 2 | +$6.93M | |
| 3 | +$6.67M | |
| 4 |
Millennium Management
New York
|
+$3.81M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$2.27M |
Top Sellers
| 1 | -$2.85M | |
| 2 | -$2.54M | |
| 3 | -$2.5M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.2M |
| 5 |
Jane Street
New York
|
-$2.11M |
